Does anti-tumour necrosis factor alpha treatment modify the tuberculin PPD response?
作者信息
Joven B E, Almodóvar R, Galindo M, Mateo I, Pablos J L
出版信息
Ann Rheum Dis. 2006 May;65(5):699. doi: 10.1136/ard.2005.040055.
Abstract
摘要
相似文献
1
Does anti-tumour necrosis factor alpha treatment modify the tuberculin PPD response?
Ann Rheum Dis. 2006 May;65(5):699. doi: 10.1136/ard.2005.040055.
2
Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vgamma9/Vdelta2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?
Reumatismo. 2009 Jan-Mar;61(1):21-6. doi: 10.4081/reumatismo.2009.21.
3
Unaffected reaction level in tuberculin skin test by long-term therapy with tumor necrosis factor inhibitors for rheumatoid arthritis.
Int J Rheum Dis. 2017 May;20(5):584-588. doi: 10.1111/1756-185X.13101. Epub 2017 May 19.
4
Is it safe to use anti-TNF-α agents for tuberculosis in children suffering with chronic rheumatic disease?
Rheumatol Int. 2012 Sep;32(9):2675-9. doi: 10.1007/s00296-011-2030-8. Epub 2011 Jul 26.
5
[Comprehension and prevention of infections using TNF inhibitors].
Rev Med Interne. 2005 Oct;26 Spec No 1:39-41.
6
Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients.
Rheumatol Int. 2012 Sep;32(9):2769-75. doi: 10.1007/s00296-011-2017-5. Epub 2011 Aug 7.
7
Low prevalence of reactive PPD prior to infliximab use: comparative study on a population sample of Hospital Geral de Fortaleza.
Rev Bras Reumatol. 2011 Jan-Feb;51(1):40-52.
8
Tumour necrosis factor alpha inhibitors: screening for tuberculosis infection in inflammatory bowel disease.
Med J Aust. 2008 Feb 4;188(3):168-70. doi: 10.5694/j.1326-5377.2008.tb01565.x.
9
How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study.
Dig Liver Dis. 2013 Sep;45(9):733-7. doi: 10.1016/j.dld.2013.03.005. Epub 2013 Apr 12.
10
Infliximab does not suppress the tuberculin skin test (purified protein derivative).
J Rheumatol. 2007 Mar;34(3):474-80. Epub 2007 Feb 1.
引用本文的文献
1
Characterisation of the clinical and activated T cell response to repeat delayed-type hypersensitivity skin challenges in human subjects, with KLH and PPD, as a potential model to test T cell-targeted therapies.
Inflamm Res. 2016 May;65(5):389-404. doi: 10.1007/s00011-016-0923-4. Epub 2016 Mar 11.
2
TNF-alpha antagonist therapy modify the tuberculin skin test response.
Rheumatol Int. 2011 Sep;31(9):1147-51. doi: 10.1007/s00296-010-1424-3. Epub 2010 Mar 27.
3
Increased risk of tuberculosis in patients treated with antitumor necrosis factor alpha.
Clin Rheumatol. 2009 Apr;28(4):421-6. doi: 10.1007/s10067-008-1067-x. Epub 2008 Dec 4.
4
Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors.
Clin Rheumatol. 2009 Feb;28(2):167-72. doi: 10.1007/s10067-008-1007-9. Epub 2008 Sep 16.
5
Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment.
Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):907-13. doi: 10.1007/s10096-008-0519-1. Epub 2008 May 10.
本文引用的文献
1
TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection.
J Clin Invest. 2004 Feb;113(3):401-13. doi: 10.1172/JCI18991.
2
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003).
Ann Rheum Dis. 2003 Nov;62 Suppl 2(Suppl 2):ii2-9. doi: 10.1136/ard.62.suppl_2.ii2.
3
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
Arthritis Rheum. 2003 Aug;48(8):2122-7. doi: 10.1002/art.11137.
4
Role of cytokines in rheumatoid arthritis.
Annu Rev Immunol. 1996;14:397-440. doi: 10.1146/annurev.immunol.14.1.397.
5
Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.
Immunity. 1995 Jun;2(6):561-72. doi: 10.1016/1074-7613(95)90001-2.
6
Delayed cutaneous hypersensitivity in rheumatoid arthritis: the influence of nutrition and drug therapy.
Clin Rheumatol. 1984 Mar;3(1):39-45. doi: 10.1007/BF02715694.
7
Impaired delayed type cutaneous hypersensitivity in rheumatoid arthritis reversed by chrysotherapy.
Ann Rheum Dis. 1989 Feb;48(2):108-13. doi: 10.1136/ard.48.2.108.
Zotero 插件